← Eichor
Study identifier: NCT06529835 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

Condition: Peripheral Nerve Injuries  ·  Sponsor: Auxilium Biotechnologies

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.

This description comes directly from the study's public registry record.

Talk to the study team

Jacob Koffler, PhD, MBA  ·  858-699-9443  ·  j.koffler@auxiliumbio.com

Always discuss trial participation with your own doctor first.

Locations (8)

UC San Diego HealthSan Diego, California, United StatesRecruiting
UCSF Orthopedic InstituteSan Francisco, California, United StatesRecruiting
Medstar Union Memorial Hospital- The Curtis National Hand CenterBaltimore, Maryland, United StatesRecruiting
NYU Langone Orthopedic CenterNew York, New York, United StatesRecruiting
OSU Wexner Medical CenterColumbus, Ohio, United StatesRecruiting
University of Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania, United StatesRecruiting
UT Health HoustonHouston, Texas, United StatesRecruiting
The San Antonio Orthopaedic Group (TSAOG Orthopaedics)San Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06529835